Palliative Care for Lung Cancer: 12 Real Stories

Extensive-stage small cell lung cancer: multi-line treatment complicated by glucocorticoid-refractory immune-related cystitis

Patient Info: Anonymized, Male, 50s

Biomarkers: No molecular biomarkers reported for SCLC. Bladder biopsy during cystitis showed mostly CD3/CD8-positive T-cell inflammation.

As of December 2025, the cancer had progressed through multiple systemic lines, new brain metastasis had appeared, and care had shifted to palliative symptomatic treatment; immune-related cystitis had resolved after prednisone plus mycophenolate mofetil.

PubMed CentralRead more →

Small cell lung cancer with anti-SOX1 paraneoplastic limbic encephalitis: fatal autopsy case

Patient Info: Anonymized, Male, 60s

Biomarkers: SCLC with strong anti-SOX1 antibody, ProGRP elevation, neuroendocrine markers positive

As of November 2025, this fatal case ended on hospital day 115 after anti-SOX1 paraneoplastic limbic encephalitis associated with right hilar small cell lung cancer; autopsy confirmed SCLC and severe limbic nervous-system injury.

PubMed CentralRead more →

Stage IV Large-Cell Neuroendocrine Lung Cancer Controlled for Nearly Four Years With Multiple Treatments

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: PD-L1 high initially; no actionable driver mutation; later PD-L1 5%

Metastatic Site: liver, bones

After several partial responses across multiple treatment lines, she entered hospice and died on December 13, 2024, after an overall survival of 47 months.

PubMed CentralRead more →

Fatal Multiorgan Failure After Pembrolizumab-Based Treatment for Metastatic Lung Cancer

Patient Info: Anonymized, female | Stage IV

She died less than 12 hours after hospital presentation with rapidly progressive multiorgan failure one week after the first pembrolizumab-based treatment cycle; immune-related toxicity was strongly suspected, although the rapid decline limited full evaluation.

PubMed CentralRead more →

Stage IV Non-Small Cell Lung Cancer: Tim's Patient Story

Patient Info: Tim Monds, Male, 50s | Stage IV

Biomarkers: High PD-L1 expression

Metastatic Site: Other lung lobes / lung nodules

As of March 2024, Tim Monds was identified as a Stage IV lung cancer survivor involved in discussion of the PaCES early palliative-care project and broader lung cancer advocacy.

Lung cancer first discovered through a skin metastasis

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: skin and subcutaneous tissues; soft tissue and muscle;…

His metastatic disease progressed rapidly, and he died 4.5 months after the initial dermatology referral.

PubMed CentralRead more →

Recurrent NRG1-Fusion Lung Cancer After Surgery and Immunotherapy

Patient Info: Anonymized, Male, 60s | Stage Metastatic/Advanced

Biomarkers: SDC4-NRG1 fusion

He chose no further treatment after rapid progression on afatinib and died shortly afterward in hospice.

PubMed CentralRead more →

Lung adenocarcinoma first presented through skin and haemorrhagic brain metastases

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: TTF-1-positive; CK7-positive; CEA-positive; PD-L1 10%; EGFR-negative; ALK-negative; ROS1-negative; BRAF-negative

Metastatic Site: skin|brain

Her condition declined rapidly after brain radiation, systemic therapy could not be started, and she died from metastatic lung cancer within 6 weeks of presentation.

PubMed CentralRead more →

Advanced Lung Cancer With Extreme White Blood Cell Counts and Poor Circulation

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: PD-L1 70%

Metastatic Site: contralateral lung|bone (left iliac)

After a mixed but mildly improved response to three pembrolizumab cycles, she developed severe paraneoplastic leukocytosis, arterial ischaemia, and acute respiratory failure and died after choosing comfort measures.

PubMed CentralRead more →

Small-Cell Lung Cancer First Appeared as Rapidly Worsening Nerve Damage

Patient Info: Anonymized, Female, 60s

Biomarkers: Anti-Hu-positive; anti-CV2/CRMP5-positive; anti-SOX1-positive

Despite six cycles of carboplatin and etoposide and intensive treatment for the paraneoplastic neuropathy, her neurological condition progressed; after a thrombocytopenia-related brain haemorrhage, she entered palliative care and died within weeks.

PubMed CentralRead more →

Metastatic Lung Adenocarcinoma Presenting After Kidney Transplant

Patient Info: Anonymized, Male, 50s | Stage Metastatic/Advanced

Biomarkers: TTF-1 positive

Metastatic Site: bone marrow|spine|bony pelvis

His condition deteriorated rapidly, and he died 1 week after the lung-cancer diagnosis.

PubMed CentralRead more →

Final lung cancer blog entry: respiratory failure, palliative sedation, and family tribute

Patient Info: Anonymized, Male

The patient died on 3 April after living with lung cancer diagnosed in February 2014; his family described respiratory failure, ICU care, and his decision to use palliative sedation under his living will.